Demystifying Long COVID International Conference 2024

• Abstract Submission Portal is now open! For more information, click here.

The Demystifying Long COVID International Conference 2024 will be held on 21 - 23 November 2024. This conference aims to raise awareness, clarify misconceptions, promote understanding, and stimulate discussion amongst healthcare professionals, investigators, policymakers, and community representatives on the clinical manifestations, management, plausible preventive and therapeutic options, and public health challenges related to Long COVID (or post-acute sequelae of COVID-19).

Knowledge of symptom-specific testing and diagnostic recommendations for Long COVID is still limited. The possible protective role of vaccination remains an extensive area of research, likewise the possible effect of antiviral and other treatment strategies. This highlights the importance of sustained medical education and regular updates on guidelines.

The program will feature state-of-the-art lectures, case presentations, and interactive sessions tailored to address educational needs in global healthcare settings. Ample time is reserved for debates and panel discussions to enhance knowledge exchange and reinforce the implementation of clinical guidelines and recommendations.

This will be done in the unique context of the COVID-19 pandemic considering regional differences in epidemiology, morbidity and mortality, access to vaccines, tests, and medications, health system capacity, and public health measures.

We trust that the following information will assist you in organizing your participation for the Demystifying Long COVID International Conference 2024.

Physical Participation

Virtual Participation

Discounts

* The "Regular Delegate" category includes the following:

• Healthcare professionals and patient representatives;
• NGOs, activists, and lobbyists;
• Government officials, representatives, and policymakers;
• Researchers; and
• Students in a relevant field.

Healthcare professionals are defined as professionals that provide any type of health care service to patients living with HIV or other diseases. If you are not sure, please do not hesitate to contact us at hana.agustine@amededu.com.

**RLS are countries included in the low-income and middle-income economies list of the World Bank Classification

If you have financial concerns, please contact the conference secretariat.

• We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.

• Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the conference, identify interesting topics and candidate speakers, and review all submitted abstracts.

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, they participate in reviewing submitted abstracts, and play an active role during the conference as moderators and/or chairs of sessions. 

• Giovanni Guaraldi, MD - University of Modena and Reggio Emilia, Italy
• Danilo Buonsenso, MD, PhD - Woman and Child Health and Public Health Rome, Italy
• Tomaso Antonacci - Ville de Florenville, Belgium
• Pauline Oustric, PhD - #ApresJ20 Association Covid Long France, INSERM/Centre Léon Bérard, France
• Clara Lehmann, MD - German Center For Infectious Research, University Hospital Cologne, Germany

The Demystifying Long COVID International Conference 2024 accepts new original data as well as encored abstracts. All abstracts must contain up-to-date information at the time of the conference. 

Please note:

• Abstracts must be submitted in English. 
• Registration fees are WAIVED for all abstract presenters that qualify as either academia from Resource-Limited Settings or Early-Career Investigators. A 50% discount is offered for those without an accepted abstract. The requirements for the application are specified here.
• Abstracts will be accepted either for oral or poster presentations. Presenters of all accepted abstract are expected to attend in person. Virtual presentations will not be accepted.

For purposes of review and programming, abstracts are divided into topical categories.

The selection of the most appropriate category is important as it determines who reviews your abstract. The Review Committee reserves the right to reassign your abstract to a more appropriate category.

Abstract submission topics for submissions:

• Epidemiology
• Syndrome Definition and Diagnosis
• Pathophysiology
• Long COVID in Diverse Populations
• Prevention of post-COVID conditions
• Treatment Strategies and Clinical Trials
• Clinical Management and Models of Care
• Economic Impact
• Pediatrics
• Biostatistics
• Pregnancy
• Social Determinants of Health

Abstracts should contain the following four components:

• Background: A concise statement of the issue under investigation or a hypothesis;
• Material and Methods: The experimental methods used (including the statistical analyses employed);
• Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
• Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 350 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled. 

We encourage you to use person-first language in your abstract(s). View our guidelines here.
 

Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in the Demystifying Long COVID-19 International Conference 2024.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Ms. Kim Go at kim.go@amededu.com.
 

By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

• Symposium opportunities
• Non-commercial interviews with company representatives
• Verbal acknowledgement during the program 
• Discounted and complimentary registrations for your representatives
• Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
• Company acknowledgement on printed meeting materials including but not limited to banners and the program book
• Digital and printed advertising opportunities 
• Social media shout-outs
• Logo on the conference bag 

 
*Subject to the support level.

• 1st Edition - Demystifying Long COVID-19 International Conference 2023

The Demystifying Long COVID International Conference 2024 is endorsed by the following societies and organizations.  Their support and collaboration are key to the success of this conference!

If you would like your organization to endorse or become a media partner of the Demystifying Long COVID International Conference 2024, please contact Ms. Hana Agustine at Hana.Agustine@amededu.com.